Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Evaluating the Accuracy of Alzheimer’s Mouse Models through Cross-Species Meta-Analysis of Gene Expression Patterns
EF 2024-25
Résumé
Alzheimer disease (AD) is an age-associated neurodegenerative disease and the leading cause of dementia. Despite the growing disease burden, no treatments today can effectively prevent disease progression. AD research mainly relies on genetically engineered mice that express human genes associated with increased risk for AD. It is known that existing mouse models do not capture the spectrum of AD phenotypes and disease progression patterns seen in most human patients. Thus, a challenge in the field is the faithful replication of human AD features in mouse models. Despite this problem, mice remain a cost-effective and powerful model to study AD. So, it is essential to enhance our understanding of how closely mice resemble or deviate from human disease features to improve outcomes from AD research and therapy development. One way to evaluate the reliability of these models, is comparing single-cell gene expression patterns between human patients and AD mouse models, since cell types are more conserved between species compared to tissue composition and organization. Therefore, my proposed research aims to determine how accurately existing mouse models of AD reflect human AD features, by comparing gene expression patterns in different brain cell types between AD patients and mouse models. Combining gene expression data from various AD studies, I aim to identify genes in distinct brain cell types that are differentially expressed in diseased cells compared to healthy cells in both humans and mice. Based on these results, I will verify if disrupted cellular pathways in human AD are either reliably or poorly translated in mouse models. Using these insights we can modify our use of mouse models for AD research to ultimately enhance development of effective AD treatments.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529743
Name
Datar Isha G
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the Accuracy of Alzheimer’s Mouse Models through Cross-Species Meta-Analysis of Gene Expression Patterns
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Differential Expression; Gene Expression Profiles; Meta-Analysis; Mouse Models Of Alzheimer'S Disease; Neurodegenerative Disease; Pathology; Single-Cell Transcriptomics
Abstract
Alzheimer disease (AD) is an age-associated neurodegenerative disease and the leading cause of dementia. Despite the growing disease burden, no treatments today can effectively prevent disease progression. AD research mainly relies on genetically engineered mice that express human genes associated with increased risk for AD. It is known that existing mouse models do not capture the spectrum of AD phenotypes and disease progression patterns seen in most human patients. Thus, a challenge in the field is the faithful replication of human AD features in mouse models. Despite this problem, mice remain a cost-effective and powerful model to study AD. So, it is essential to enhance our understanding of how closely mice resemble or deviate from human disease features to improve outcomes from AD research and therapy development. One way to evaluate the reliability of these models, is comparing single-cell gene expression patterns between human patients and AD mouse models, since cell types are more conserved between species compared to tissue composition and organization. Therefore, my proposed research aims to determine how accurately existing mouse models of AD reflect human AD features, by comparing gene expression patterns in different brain cell types between AD patients and mouse models. Combining gene expression data from various AD studies, I aim to identify genes in distinct brain cell types that are differentially expressed in diseased cells compared to healthy cells in both humans and mice. Based on these results, I will verify if disrupted cellular pathways in human AD are either reliably or poorly translated in mouse models. Using these insights we can modify our use of mouse models for AD research to ultimately enhance development of effective AD treatments.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Datar, Isha G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~